Segment Information

3 Months Ended

Dec. 27, 2013

Segment Information

17. SEGMENT INFORMATION

The Company’s operations are grouped into two reportable operating segments: Oncology Systems and X-Ray Products. These reportable operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The Company’s Ginzton Technology Center, Security and Inspection Products business and Varian Particle Therapy business are reflected in the “Other” category because these operating segments do not meet the criteria of a reportable operating segment. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.

The following table summarizes selected operating results information for each business segment:

	Three Months Ended
(In millions)	December 27, 2013			December 28, 2012
Revenues
Oncology Systems	$	542		$	524
X-Ray Products		145			133
Total reportable segments	$	687		$	657
Other		25			21
Total company	$	712		$	678
Operating Earnings (Loss)
Oncology Systems	$	121		$	120
X-Ray Products		39			34
Total reportable segments	$	160		$	154
Other		(13	)		(11	)
Corporate		(5	)		(6	)
Total company	$	142		$	137